Is there a physiological advantage in targeting specific HDAC complexes?
How redundant are the roles of the individual class I HDAC complexes in gene regulation?
Are there alternative allosteric sites on HDACs that could be used to enhance the isoform-specificity of HDAC inhibitors?
What are the mechanisms for targeting HDAC complexes to the genome and can these be targeted by inhibitors?